About UsSrijan has carved out for itself, a special reputation in the field of sales and marketing. In India, the strength of Srijan's sales and marketing, along with its expertise in brand buildings are recognized widely and are considered as amongst the very best. Some of the biggest brands in the Indian Pharma market are the Srijan brands. The Srijan product portfolio encompasses a wide spectrum of therapeutic groups, ranging from Anti bacterial, NAIADS, Gastro Entomology products, Gynecology products, CNS and CVS products along with an impressive oncology range. SRIJAN has shown remarkable success with new products and converted several of them into market leaders. For a company with patented new molecules, seeking sales and marketing partners in India, SRIJAN emerges as the ideal Indian partner. Research and development are its major focus areas and Srijan has undertaken several initiatives and activities in order to continue a steady process of enhancement in these areas. Srijan possesses its own CRO. Srijan aims to continually improve in its rankings in India and simultaneously spread its wings within the international market. |
Aim / Vision / Mission Aim Our aim is to become a innovative pharmaceutical conglomerate with a zeal to compete and create ideas to be followed by others. We aim to be become the best in quality and one of the top twenty companies of the globe. Vision Our vision is to lead Indian the pharmaceutical and health care management and to become a key global by providing the best quality in our products and making India key to new medical and pharmaceutical revolution Mission We will strive to discover , develop and market the pharmaceutical products to help the humanity to get rid of all , the diseases, We will strive for total customer satisfaction and lead in the market , products and segments of our services across the globe , using latest technologies of research and development our mission is to serve the human being which will be governed by our ethics of high standards in corporate life.
Testing FacilitiesTesting Facilities Srijan has reinforced its focus on R & D and has substantially scaled up on its investments to build its capabilities in all the areas of generic research as a short to medium term strategy. Generic drug development encompasses both small and large molecules. Srijan strongly believes that there are attractive opportunities in the highly competitive global generic space, not only in vanilla generics but also in value added and difficult to develop complex generics. The business focus is backed with the building up of captive manufacturing operations and of complying with the regulatory standards of the advanced markets. Focus on the generics business strategy will provide the company with a sustainable model to move up the value chain. Today, the company includes a group of more than 200 R & D scientists, with performance driven credentials, in all the disciplines of generic drug development, as their asset to steer forward in its current aspirations. Srijan has an aspiration to make pioneer within the area of drug discovery, sometime in the recent future, and is looking into various models and therapeutic segments to carve out a meaningful space in the arena of medical needs that are not fulfilled. Srijan has in-licensed a number of novel products for the domestic market, form overseas collaborators, and continue to do so to provide the most advanced therapy avenues to the Indian patients. Srijan is also collaborating with several Indian Universities and Indian companies for their development of difficult-to-make products and the development of other unique technologies. Srijan is progressing with leaps and bounds in the Nutraceutical segment of healthcare and wellness. Nutraceutical R & D efforts are mainly directed towards providing low fat and low calorie nutritional products for the better management of health. Commendable success has been achieved in this area of research and development. Srijan is building its future upon appropriate and timely protection of its R & D efforts. A number of patent applications are emerging from the in-house innovations which have gone on to be filed
|
 | Fact Sheet | | | Year of Establishment | : | 2002 | | Nature of Business | : | Wholesaler, Trader | | Number of Employees | : | 51 to 100 People | | Turnover | : | Upto US$ 0.25 Million (or upto Rs. 1 Crore Approx.) | | Major Markets | : | Indian Subcontinent, East Asia, Middle East and South East Asia |
|
|
Contact Details| | Company Name:
| Srijan Health Care Private Limited | | Contact Person: | Mr. S. V. Rao | | Telephone: | +(91)-(11)-65692281
| | Mobile / Cell Phone: | +(91)-9939407005 | | Address: | 1201-B, Antriksh Bhawan, 22, K.G Marg,, New Delhi, Delhi - 110001 (India) |
|
|
Processing...
